Independent · Educational · Not medical advice
Navigate peptide therapy without the chaos.
Plain-English guides, provider comparisons, and tracking tools for people considering GLP-1 and peptide-based treatments. We don't sell, prescribe, or endorse — we help you ask better questions.
Peptide therapy is going mainstream. The consumer experience hasn't caught up.
Unclear legality
Branded, compounded, and 'research' products are sold side by side with very different legal footing.
Inconsistent provider quality
From async forms to board-certified follow-up — same category, very different oversight.
Bad education
Marketing copy answers most of what people read, and almost none of what they actually need to know.
Tool 01 — Doctor-discussion checklist
“Am I ready for a GLP-1 conversation?”
Six questions. Tailored questions to bring to your clinician, a list of red flags to avoid online, and a starter tracking template. No diagnosis, no recommendation.
Take the 2-minute quiz- Questions to ask your clinician
- What to prepare before your appointment
- What not to buy online
- Starter tracking template
Tool 02 — Provider transparency
Provider comparison, side by side
| Provider | Type | Pricing |
|---|---|---|
| Sample Telehealth A | Compounded | $0 intake / $129 mo |
| Sample Clinic B | Both | $249 intake / $89 mo |
| Sample Telehealth C | Compounded | $49 intake / $199 mo |
Sample data — verify each provider directly before deciding.
Cornerstone guides
Start here
Foundations
Oral semaglutide is now available in the US — here's what that actually means
Two FDA-approved semaglutide pills launched in 2026 — one for type 2 diabetes, one for weight loss. Here's who each is for, how they differ from the shot, and what to ask your doctor.
5 min read
Medications
What is retatrutide?
An overview of retatrutide — an investigational triple-hormone agonist being studied for obesity and metabolic disease, and why it is not yet available by prescription.
6 min read
Dosing concepts
How semaglutide dosing is typically structured
How clinicians generally think about semaglutide titration — starting low, escalating slowly, and what to discuss with your prescriber. Not a dosing instruction.
6 min read
Dosing concepts
How retatrutide dosing appears in clinical trials
A research-framed summary of how retatrutide has been dosed in published trials. Retatrutide is investigational and not available by prescription.
6 min read
Comparisons
Semaglutide vs retatrutide: what we know so far
How semaglutide and retatrutide compare on mechanism, evidence, availability, and what is actually known about them in 2025.
7 min read
The weekly brief
A plain-English brief on GLP-1s, peptides, and the business behind them.
FDA updates, new studies translated, provider and pricing shifts, and one practical tracking tip — in your inbox once a week.